🚨 Trade Update: IBM — Both Price Targets Hit ✅✅
We recommended International Business Machines Corporation (NYSE: IBM) on May 22, 2026, at a buy level of $254.00, with price targets of $296.00 (PT1) and $324.00 (PT2) and a stop-loss at $230.00 on a closing basis.
Both targets have been achieved — PT1 and PT2 were both reached on June 1, 2026, just over a week after our call — delivering gains of approximately 17% and 28% from the entry level. The stock has since pulled back and is currently trading around $234.19.
How to manage the position from here: Traders who followed our guidance to trail a stop to $296.00 (our PT1) after PT2 hit would have been stopped out on the subsequent pullback, locking in a minimum ~17% gain well ahead of the stock’s retreat to current levels. No active position remains under our original plan.
Bottom line: IBM hit both targets in just over a week for gains of ~17% and ~28% — a trailing stop at PT1 would have locked in the win ahead of the subsequent pullback. And now, on to today’s featured setup…
Interactive Brokers Group, Inc. (NASDAQ: IBKR) just broke out of a textbook three-month bull flag to a fresh 52-week high on a powerful +5.52% single-session surge — and looks headed even higher.
As we’ll get to just ahead, the combination of a major new international partnership, accelerating growth across every key business metric, and a fresh technical breakout makes IBKR one of the more interesting setups on the board. Here’s what’s going on…
The Themes Behind the Move
Interactive Brokers is a U.S.-based automated electronic broker that gives individual investors, professional traders, hedge funds, and institutions unified access to stocks, options, futures, foreign exchange, bonds, precious metals, and cryptocurrencies across more than a hundred markets worldwide — all through a single low-cost account.
In plain English, when a hedge fund needs to trade Brazilian futures at 3 a.m., a Korean retail investor wants to buy U.S. equities from Seoul, or a registered investment advisor needs a single platform to custody thousands of client accounts, Interactive Brokers is one of the very few firms in the world that can serve all three from the same infrastructure. Its business hinges on rising customer accounts and equity, the interest income earned on client cash and margin loans, commissions from active trading, and the continued global expansion of its low-cost multi-asset trading platform.
IBKR’s latest move reflects a powerful confluence of developments — operational, commercial, and strategic — that have come together in rapid succession to fundamentally reframe the company’s near-term growth trajectory.
| Theme / Catalyst | What Happened | Why Traders Care |
|---|---|---|
| Landmark South Korea partnership with Daol | On August 24, 2026, IBKR announced a strategic collaboration with South Korea’s Daol Investment & Securities that lets eligible Korean investors access global equities via Daol’s platform running on IBKR’s infrastructure — a white-label, technology-plus-local-broker model. It extends the same playbook IBKR used for Korea Exchange access and its Nextrade ATS launch in June. | South Korea is a large, underpenetrated market for low-cost global trading. Overseas adoption acts as a natural hedge against U.S. rate cycles and taps into a fast-growing pool of Asia-Pacific retail demand. Layered on top of earlier expansions into B3 Brazilian futures, the Bucharest Stock Exchange, and Paysafe LatAm funding, IBKR is systematically wiring itself into every major regional market ahead of competitors. |
| Record commercial and platform momentum | Q2 2026 customer equity hit $930.3B (+40% YoY), active accounts surged +34% YoY to 5.19M, and margin loans jumped +67% YoY to $108.5B. Recent product launches include MCP AI connectors that let clients hook ChatGPT, Claude, Grok, Perplexity, and Cursor to live accounts (orders still human-approved), expanded overnight trading (volumes nearly tripled YoY in Q2), and new prediction-market and crypto offerings. | This is share gain via product surface area — not just riding a bull-market tape. Every new country connection, asset class, and platform integration compounds the flywheel: more accounts drive more equity, more equity drives more margin balances, more margin drives more interest income, and each new product surface brings in new customers. Very few businesses in financial services scale this cleanly. |
| Sector tailwinds — dispersion, volumes, and the day-trading rule change | Elevated market dispersion is driving record trading volumes across the industry. The old $25,000 pattern-day-trader minimum was replaced by risk-based intraday margin effective June 4, 2026 — a structural rule change that lifts industry volumes and margin balances. At the same time, the broader shift toward 24-hour trading, cross-border equities, prediction markets, and crypto is expanding the total addressable market for multi-asset brokers. | IBKR is the low-cost, multi-asset pipe for exactly the trends now defining the industry. While competitors specialize, IBKR sits at the intersection of every major growth vector — international expansion, extended trading hours, new asset classes, and institutional demand for a single global platform. That positioning turns industry tailwinds directly into top-line growth. |
| Strengthened fundamentals — Q2 blowout with 77% pretax margins | Q2 2026 revenue came in at $1.90B (+28% YoY), beating consensus by ~$100M, with diluted EPS of $0.69 (vs $0.51 last year and ~$0.64 consensus). Pretax margin held at a staggering 77% — the seventh straight quarter above 70%. Commissions rose +30% to $673M, net interest income grew +23% to $1.06B. Group equity stands at $22.3B, with management citing ~$10.3B in excess capital. | A 77% pretax margin is essentially unheard of in traditional financial services — IBKR runs more like a high-margin software platform than a brokerage. Combined with a fortress balance sheet, over $10B in excess capital, and every key line item still growing at 20%–40%+ rates, IBKR has the growth profile of a tech name and the profitability of a monopoly utility. |
| Analyst coverage | Among the 12 analysts covering IBKR, the average 12-month price target sits at $96.89 — technically implying modest downside from current levels, but the stock has clearly raced past that older mean and Tier-1 desks are catching up fast. The high target is $114.00, implying roughly 16% upside. Recent actions are uniformly constructive: Barclays (Benjamin Budish) reaffirmed Overweight with a $114 target; BMO (Brennan Hawken) at Outperform with $110; BofA (Craig Siegenthaler) at Buy with $114; and Goldman (James Yaro) at Buy with $114 as of August 25. | The old average target is stale, but the top-tier bank consensus is uniformly bullish at $114 — a cluster of four major desks landing at the same level suggests coverage is actively re-rating IBKR into the breakout. When the mean is behind and the highest-conviction desks are aligned at the top of the range, that’s precisely the setup where estimate revisions can chase price higher. |
| Market conviction signal | The breakout came on a decisive +5.52% single-session move on visibly expanded volume, pushing IBKR to a fresh 52-week high near $99.20 and clearing a textbook three-month bull flag on the daily chart. Zoom out and the conviction runs deeper: customer accounts have compounded to 5.19M in Q2 (+34% YoY), and the July monthly update logged 5.32M accounts — growth still accelerating even as the tape has whipsawed. | When a stock decisively clears a multi-month consolidation to fresh 52-week highs on outsized volume — and the underlying business is compounding accounts and equity at 30%+ annually straight through the noise — that’s the kind of tape-plus-fundamental signal that suggests institutional money is buying into the story, not just chasing momentum. |
| Upcoming triggers | Traders are watching the September 1 ex-dividend date and September 14 pay date, the mid-September release of August 2026 monthly performance metrics (daily average revenue trades and account growth), Q3 2026 earnings around October 15 (consensus ~$0.65 EPS), and the year-end target to have Interactive National Trust Bank operational (OCC preliminary conditional approval already in place — the bank is designed to bring fund/ETF custody and securities lending in-house). Ongoing catalysts include additional country market launches, AI-connector usage stats, and prediction-market volume trends. | A staggered set of high-conviction catalysts — monthly metrics, dividend cadence, earnings, and a brand-new trust-bank vertical — each capable of independently moving the stock through the back half of 2026 and into 2027. |
If needed, swipe or scroll sideways to view the full table.
Put it all together, and IBKR is looking less like an expensive broker priced for peak-cycle earnings and more like a rapidly compounding, high-margin global trading platform — with a fortress balance sheet, accelerating international expansion, and record fundamentals converging just as the chart breaks out to a fresh 52-week high.
The story is getting stronger, but the chart is what could determine whether this move has more room to run in the near term. Here are the bullish technical signals traders should be watching now.
Bullish Technical Signals
#1 Flag Pattern Breakout (Daily): IBKR has resolved a textbook bull flag on the daily chart. The “pole” is the steep March–May advance that carried the stock from the mid-$60s to nearly $98 — a roughly 50% run in eight weeks. The “flag” is the orderly, downward-sloping consolidation that followed, with price drifting inside a tight channel (purple) for about three months. That pause did exactly what a healthy flag should — it cooled overbought conditions, shook out late longs, and reset momentum indicators without surrendering the pole’s gains. Today’s decisive move through the flag’s upper boundary — a +5.52% session on visibly expanded volume — is the clean trigger. Because flags are continuation patterns by construction, the breakout argues the larger uptrend is resuming rather than reversing, and the measured-move projection from the pole’s height lands in the same zone as the price targets below, so pattern and objectives corroborate one another.
IBKR – Daily Chart
#2 Price Above the 50- and 200-Day SMAs (Daily): IBKR is trading well above its rising 50-day SMA ($92.03) and 200-day SMA ($77.90), with the 50-day stacked above the 200-day — the bullish golden-cross alignment that confirms momentum points up across both short- and long-term horizons. Both averages are positively sloped and now define a tiered support shelf (~$92, then ~$78) that buyers can lean on if the breakout is retested. One caveat worth stating plainly: today’s 5%+ session leaves price meaningfully extended above the 50-day, and a controlled pullback toward that average would be a normal breather rather than a break in the thesis. That’s precisely why the buy trigger sits above $99.20 — the setup asks for continuation above today’s high, not a chase into an extended candle.
#3 Bullish RSI (Daily): The daily RSI has pushed from the 50 midline up to ~63, with the signal line (~52) still catching up — a clean momentum handoff, not a hovering read. Two things make this reading worth its weight. The move through 50 confirms buyers have structurally taken the tape from sellers; the continued upslope tells us that momentum is building, not stalling near the pivot. Just as important, at ~63 the indicator is firmly bullish but still comfortably short of the 70 overbought threshold, meaning there’s runway before RSI itself becomes a headwind. That combination — above equilibrium, rising, but not yet stretched — is the sweet spot for trend-following entries.
#4 Bullish MACD (Daily): The MACD histogram has flipped positive and is expanding, confirming a fresh bullish crossover with both the MACD and signal lines curling higher well above the zero line. Two contextual points sharpen the signal. First, the crossover is firing as price breaks out of the flag — the indicator is corroborating the structural trigger rather than diverging from it, which is the higher-quality version of this signal. Second, both lines sitting above zero means this isn’t an early-cycle bounce off a deep base; it’s a re-acceleration inside an already-established uptrend, which is what you want to see coming out of a continuation pattern. A widening histogram on the breakout candle points to trend acceleration in its early stages.
#5 Support Area Holding, Price Above Weekly SMAs (Weekly): Zooming out, the weekly chart reframes the daily breakout inside a much larger structural context. The pink dotted level near $92.66 marks a resistance-turned-support zone that was tested on the July–August pullback and, on a weekly closing basis, held — the classic polarity shift where a former ceiling becomes a floor. Price is now firmly back above that level, trading comfortably above the rising 50-week ($76.49) and 200-week ($43.46) SMAs, with the 50-week extending its slope above the 200-week — a golden-cross alignment intact on the higher timeframe. The scale here matters: IBKR has advanced from roughly $20 in early 2024 to just under $100 today, a multi-year secular uptrend that the current flag breakout is extending rather than initiating. When daily and weekly agree at this level of structural alignment, the signal carries far more weight than either timeframe alone.
IBKR – Weekly Chart
#6 Bullish Aroon (Weekly): The weekly Aroon is registering the strongest possible bullish configuration — Aroon Up pinned at 100 while Aroon Down sits at just 7.14, an unusually wide separation. Aroon Up at its ceiling means IBKR has printed a fresh high within the lookback window very recently, consistent with this week’s breakout; the collapsed Aroon Down confirms that meaningful new lows are completely absent from the picture. That kind of one-sided participation profile — buyers active, sellers effectively silent — points to a well-established, uncontested uptrend rather than a fledgling one still fighting for direction. Stacked against the weekly support hold and the daily flag breakout, all three structural reads point the same way.
#7 Bullish Stochastic (Weekly): On the weekly stochastic, %K (97.15) sits well above %D (81.09), confirming that buying momentum is dominant on the higher timeframe — a signal that always carries more weight on the weekly than the daily. The honest nuance: both lines are deep into overbought territory. That tells us buyers are firmly in control, but it also flags that the near-term move is stretched. Two things worth remembering here — in strong trends, weekly stochastic can stay overbought for weeks or even months without triggering a reversal, so overbought is a caution rather than a sell signal; and the higher-quality entry into an established weekly uptrend is a pullback toward support (the $92–$93 shelf), not a chase into a vertical spike. The setup’s buy trigger just above $99.20 handles this directly by asking for confirmation of continuation before commitment.
Risks to Consider
Even strong setups can fail, especially in a rate-sensitive financial name like Interactive Brokers. A few things could knock the stock off course:
- A breakdown back below the bull flag’s upper boundary on heavy volume would invalidate the breakout thesis and open the door to a retest of the ~$92 support shelf, or worse the 200-day SMA at ~$78
- Negative company-specific news or broader market weakness — any sector rotation out of high-multiple financials or a sharp risk-off tape would pressure the entire online-brokerage group
- Interest rate cuts — a 1% benchmark rate cut is modeled to reduce IBKR’s net interest income by ~$417 million annually, and CFO commentary flags ±$38M of annual net interest income sensitivity per ±25 bps in non-USD rates alone; U.S. cuts would bite harder
- Valuation compression — IBKR trades at a P/E of roughly 37–39x, well above its 5-year median, leaving limited margin of safety if account growth or margin balances decelerate for even a single quarter
- Competition — HOOD, Webull, Schwab, Futu, and a rising cohort of crypto-native brokers are all pushing on IBKR’s edges, particularly if the day-trading rule change funnels new retail activity to zero-commission apps rather than IBKR’s professional stack
- Operational risk — IBKR suffered a short-lived platform outage during U.S. hours on August 5, a reminder that reputation is uniquely sensitive for a tech-first broker whose value proposition is uptime and execution quality
- Regulatory and product-launch risk on prediction markets, crypto offerings, and the pending Interactive National Trust Bank — any delay, ruling, or scope reduction could soften the growth narrative
- Insider selling — insiders logged roughly $99 million in net sales over the past year (largely through pre-scheduled 10b5-1 plans by founder Thomas Peterffy), routine but still a sentiment overhang for skeptics
The Bottom Line
IBKR is breaking out of a textbook three-month bull flag on the daily chart while holding cleanly above a key resistance-turned-support level on the weekly — a dual-timeframe technical setup that historically signals the start of a sustained move higher.
The fundamental story underneath the chart is just as strong: record customer growth of 34% year-over-year to 5.32 million accounts, industry-leading pretax margins holding at 77% for seven straight quarters, and customer equity compounding to nearly $1 trillion.
Combine that with multiple commercial and operational catalysts staggered through the back half of 2026 and into 2027 — the August 2026 monthly performance metrics release in mid-September, Q3 earnings around October 15, the year-end launch of Interactive National Trust Bank, and a widening set of international market and product initiatives — and IBKR looks like one of the more compelling risk-reward setups on the board right now.
If this is a trade you want to get in on, here’s how we’d play it. Below you’ll find our exact entry level, both price targets that imply 16%–26% potential upside, and the stop-loss we’re using to manage the downside.
Recommended Trade Setup
| Item | Detail |
|---|---|
| Buy Level | Above approximately $99.20 |
| Price Target 1 | $115.00 — Potential upside: 16% |
| Price Target 2 | $125.00 — Potential upside: 26% |
| Timeframe | Next 3–6 months |
| Stop-Loss | $91.00 on a closing basis |
| Trade Invalidation | Void if price hits stop-loss before entry triggers |
If needed, swipe or scroll sideways to view the full table.
For a risk of approximately $8.20 per share, the target rewards are about $15.80 and $25.80 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.
Note on Trade Invalidation: This recommendation stays active as long as the technical structure holds. If IBKR drops to or below the $91.00 stop-loss before the $99.20 entry triggers, the trade is automatically void — the support underpinning the thesis would have broken, and the risk-reward setup would no longer justify entry.
Happy Trading!
Tara and Greg
🥈 Almost Made the Cut
Today’s featured trade, Interactive Brokers Group, Inc. (NASDAQ: IBKR), was our top pick of several breakout candidates we evaluated. The following two stocks were strong candidates that made it to the final round — they came up just short of the top spot, but remain on our watchlist and could be featured soon:
Merck & Co., Inc. (NYSE: MRK) — The pharmaceutical giant is fundamentally reshaping its long-term growth story on the back of a landmark late-stage clinical win for its personalized cancer vaccine in melanoma, with a major regulatory decision expected September 21 and further pivotal data due at Q4 medical conferences. The weekly chart confirms a genuine trend change with a fresh breakout above the multi-quarter downtrend, though stretched daily momentum after the run to all-time highs suggests a better entry may come on a pullback toward the $148–$150 support zone.
Climb Bio, Inc. (NASDAQ: CLYM) — This clinical-stage biotech offers the highest upside asymmetry of our finalists, with recent Truist and HC Wainwright price targets of $24–$25 implying 30%+ potential upside from current levels. The catalyst calendar is unusually dense: a September 3 R&D spotlight event kicks off a Q4 lineup featuring three separate drug readouts across multiple disease areas — providing several independent shots on goal rather than single-point binary risk. Backed by $239 million in cash with runway into H2 2028, the balance sheet fully insulates the story from near-term dilution pressure during the key catalyst window, and a pullback toward the $15–$16 base offers the cleanest entry.


